GlycoMinds
San Diego, United States· Est.
IBDX® is the most validated and cost-effective serological panel to aid in the differential diagnosis of IBD vs. non-IBD and for CD vs. UC, as well as for predicting the probability of Crohn's Disease progression.
Private Company
Total funding raised: $2.5M
About
IBDX® is the most validated and cost-effective serological panel to aid in the differential diagnosis of IBD vs. non-IBD and for CD vs. UC, as well as for predicting the probability of Crohn's Disease progression.
Diagnostics
Funding History
1Total raised:$2.5M
Seed$2.5M